skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Identification of M-CSF agonists and antagonists

Patent ·
OSTI ID:982807

The present invention is directed to methods for crystallizing macrophage colony stimulating factor. The present invention is also directed to methods for designing and producing M-CSF agonists and antagonists using information derived from the crystallographic structure of M-CSF. The invention is also directed to methods for screening M-CSF agonists and antagonists. In addition, the present invention is directed to an isolated, purified, soluble and functional M-CSF receptor.

Research Organization:
Univ. of California (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC03-76SF00098
Assignee:
Chiron Corporation (Emeryville, CA)
Patent Number(s):
6,025,146
Application Number:
08/462,069
OSTI ID:
982807
Country of Publication:
United States
Language:
English

References (3)

Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor journal November 1992
Australian Mutual Provident Society v 400 St Kilda Road Pty Ltd journal August 1989
Structure-function studies on recombinant human macrophage colony-stimulating factor (M-CSF). journal December 1994

Similar Records

Crystallization of M-CSF.alpha.
Patent · Fri Jan 01 00:00:00 EST 1999 · OSTI ID:982807

Hepatocyte growth factor can substitute for M-CSF to support osteoclastogenesis
Journal Article · Fri Nov 17 00:00:00 EST 2006 · Biochemical and Biophysical Research Communications · OSTI ID:982807

Interleukin 3 (IL 3) regulates the in vitro proliferation of both blood monocytes and peritoneal exudate macrophages: synergism between a macrophage lineage-specific colony-stimulating factor (CSF-1) and IL 3
Journal Article · Tue Jul 15 00:00:00 EDT 1986 · J. Immunol.; (United States) · OSTI ID:982807

Related Subjects